Mark Copley, MEng (Hons)
Mark Copley graduated from the University of Bath, UK, in 2000 with a Masters Degree in Aerospace Engineering. For eight years he was Technical Sales Manager and product specialist for Copley Scientific’s range of inhaler testing equipment, before becoming the Sales Director in 2009. Mark is now Chief Executive Officer for the company. Mark is considered a leading authority in testing methods and systems for MDIs, DPIs, nebulisers and nasal sprays; authoring and contributing to more than 50 published articles. He also provides application support and consultancy, runs focused training workshops for the inhaled drug testing sector of the pharmaceutical industry and sits on the editorial advisory panel of Inhalation Magazine. An invited member of the European Pharmaceutical Aerosol Group impactor sub-team, Mark has also made recommendations to the Inhalanda working group, leading to subsequent revisions to Ph.Eur. and USP monographs. As part of Copley Scientific's associate membership of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), Mark participates in a number of working groups with a view to enhancing the regulatory science of orally inhaled and nasal drug products (OINDP).
Adam Smith, MEng Cantab MIET MBCS
Adam has been automating inhaler testing for analytical laboratories since 2011, first as a director at Novi Systems Ltd and now as Automation Product Manager for Copley since their acquisition of Novi in 2019. Adam graduated with a master’s in engineering from Cambridge University and worked in the aerospace and defence industries prior to entering the world of inhalation.